Cetuximab concurrent with IMRT versus cisplatin concurrent with IMRT in locally advanced nasopharyngeal carcinoma: A retrospective matched case–control study

To evaluate the treatment efficacies and toxicities of concurrent cetuximab-based bioradiotherapy (BRT) or cisplatin-based chemoradiotherapy (CRT) in locally advanced nasopharyngeal carcinoma. :Patients with previously untreated locally advanced nasopharyngeal carcinoma were matched into pairs, and...

Descripción completa

Detalles Bibliográficos
Autores principales: Wu, Xin, Huang, Jingwen, Liu, Lei, Li, Hongmei, Li, Ping, Zhang, Jing, Xie, Li
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer Health 2016
Materias:
5700
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5265923/
https://www.ncbi.nlm.nih.gov/pubmed/27684830
http://dx.doi.org/10.1097/MD.0000000000004926

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5265923/
https://www.ncbi.nlm.nih.gov/pubmed/27684830
http://dx.doi.org/10.1097/MD.0000000000004926

Ejemplares similares